IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 112 filers reported holding IRADIMED CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $59,419 | – | 1,510 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
| Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
| RK Capital | 213,200 | $9,560,000 | 1.88% |
| Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
| G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
| EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
| Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
| EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
| Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |